IBI Silver Castle Ltd (TASE: IBIS)
Health Care · Health Care Equipment & Supplies · IL
₪40.48
-5.51% today · +121.0% 1Y
IBI Silver Castle Ltd (TASE: IBIS) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $4.89M and employs 11 people.
Over the last twelve months the share price has gained 121.0%, trading between 6.85 and 48.58.
Tweenvest scores IBI Silver Castle Ltd across four factors: quality 7/100, value 47/100, growth 91/100. Its strongest factor is growth.
IBIS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.89M
- Revenue (TTM)
- $353.80K
- P/E
- —
- EPS
- -8.32
- Dividend yield
- —
- Beta (5Y)
- 1.46
- 52-week high
- ₪48.58
- 52-week low
- ₪6.85
- Avg volume (3M)
- —
- Shares outstanding
- 360.84K
- Employees
- 11
- Next earnings
- —
About IBI Silver Castle Ltd
Silver Castle Holdings Ltd engages in the field of digital assets. The company offers bitcoin backed bonds, as well as asset and investment management services. It also develops trading strategies for managing digital currency investments. The company was formerly known as Israel China Biotechnology (ICB) Ltd and changed its name to Silver Castle Holdings Ltd in February 2022. Silver Castle Holdings Ltd was incorporated in 2000 and is based in Tel Aviv-Yafo, Israel.
- ISIN
- IL0010970544
- Founded
- 1999
- Listed since
- May 18, 2006
- Exchange
- The Tel-Aviv Stock Exchange
- Currency
- ILS
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $115.55 | -0.50% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $369.41 | -0.65% |
| Stryker CorporationNYSE: SYK | $126.81B | $330.85 | +0.08% |
| Medtronic plcNYSE: MDT | $116.66B | $91.30 | +0.18% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €160.65 | +0.94% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $47.77 | -4.19% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.53 | -0.37% |
Figures last refreshed Aug 18, 2026.